Form 8-K - Current report:
SEC Accession No. 0001144204-14-055102
Filing Date
2014-09-10
Accepted
2014-09-10 06:01:16
Documents
22
Period of Report
2014-09-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v388733_8k.htm 8-K 15529
2 EXHIBIT 99.1 v388733_ex99-1.htm EX-99.1 28614
3 GRAPHIC image_001.jpg GRAPHIC 74990
4 GRAPHIC image_002.jpg GRAPHIC 118752
5 GRAPHIC image_003.jpg GRAPHIC 97738
6 GRAPHIC image_004.jpg GRAPHIC 92581
7 GRAPHIC image_005.jpg GRAPHIC 92899
8 GRAPHIC image_006.jpg GRAPHIC 86399
9 GRAPHIC image_007.jpg GRAPHIC 90094
10 GRAPHIC image_008.jpg GRAPHIC 101721
11 GRAPHIC image_009.jpg GRAPHIC 91822
12 GRAPHIC image_010.jpg GRAPHIC 103836
13 GRAPHIC image_011.jpg GRAPHIC 103262
14 GRAPHIC image_012.jpg GRAPHIC 86384
15 GRAPHIC image_013.jpg GRAPHIC 106803
16 GRAPHIC image_014.jpg GRAPHIC 67387
17 GRAPHIC image_015.jpg GRAPHIC 87461
18 GRAPHIC image_016.jpg GRAPHIC 84091
19 GRAPHIC image_017.jpg GRAPHIC 87808
20 GRAPHIC image_018.jpg GRAPHIC 110190
21 GRAPHIC image_019.jpg GRAPHIC 111108
22 GRAPHIC image_020.jpg GRAPHIC 74163
  Complete submission text file 0001144204-14-055102.txt   2623872
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27436 | Film No.: 141094577
SIC: 2836 Biological Products, (No Diagnostic Substances)